Akoya Biosciences Inc reports results for the quarter ended in September - Earnings Summary

Akoya Biosciences

07/11/2022 22:55

* Akoya Biosciences Inc  AKYA.OQ  reported a quarterly
adjusted
loss of 47 cents​​ per share for the quarter ended in September.
The mean expectation of seven analysts for the quarter was for a
loss of 44 cents per share.
    * Revenue rose 39.9% to $18.85 million from a year ago;
analysts
expected $17.66 million. 
    * Akoya Biosciences Inc's reported EPS for the quarter was a
loss
of 47 cents​.
    * The mean earnings estimate of analysts had fallen by
about 13.5%
in the last three months.​ 
    * In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
    * Akoya Biosciences Inc shares had risen by 17.6% this
quarter and
lost 9.7% so far this year.
    * The company reported a quarterly loss of $17.87 million.
    * Wall Street's median 12-month price target for Akoya
Biosciences
Inc is $19.00 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 7 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 

This summary was machine generated from Refinitiv data November
7 at 10:55 p.m.  ​All figures in US dollars unless otherwise
stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Sep. 30 2022      -0.44          -0.47          Missed
 Jun. 30 2022      -0.37          -0.47          Missed
 Mar. 31 2022      -0.39          -0.44          Missed
 Dec. 31 2021      -0.31          -0.47          Missed